Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | HCID 178509517 | HCID 178509517 | — |
| Solvent | Pyridine | HCID 1049 | — |
| Product | HCID 178509518 | HCID 178509518 | 16% |
Reaction Steps
A mixture of 2-[1-(3-chloro-pyrazin-2-yl)-piperidin-4-yl]-1H-benzoimidazole-5-carbonitrile (150 mg, 0.68 mmol) and morpholine (3 mL) in pyridine was heated at 130° C. under microwave for 45 min. Then it was concentrated to give the crude product which was purified by column chromatography and followed by preparative HPLC to afford pure product 2-[1-(3-morpholin-4-yl-pyrazin-2-yl)-piperidin-4-yl]-1H-benzoimidazole-5-carbonitrile (30 mg, 16%). [M+1] 390. IC50 (uM) 1.996.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08946230B2 |
|---|
| Source dataset | uspto-grants-2015_02 |
|---|
| ORD ID | ord-df55ebac8f2c4728ab32941c8e4871f0 |
|---|
| Source note | uspto-grants-2015_02 |
|---|